COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 47,853 | 798,619 | SH | | SOLE | | 798,619 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 42,662 | 450,738 | SH | | SOLE | | 450,738 | 0 | 0 |
ABIOMED, Inc. | Common | 003654100 | 1,896 | 6,514 | SH | | SOLE | | 6,514 | 0 | 0 |
AC Immune SA | Shares | H00263105 | 1,777 | 171,813 | SH | | SOLE | | 171,813 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 10,673 | 272,400 | SH | | SOLE | | 272,400 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 2,105 | 93,689 | SH | | SOLE | | 93,689 | 0 | 0 |
Acceleron Pharma Inc. | Common | 00434H108 | 10,678 | 273,098 | SH | | SOLE | | 273,098 | 0 | 0 |
Achillion Pharmaceuticals, Inc. | Common | 00448Q201 | 2,285 | 616,000 | SH | | SOLE | | 616,000 | 0 | 0 |
Adamas Pharmaceuticals, Inc. | Common | 00548A106 | 399 | 16,699 | SH | | SOLE | | 16,699 | 0 | 0 |
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 9,607 | 855,468 | SH | | SOLE | | 855,468 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 10,010 | 13,000,000 | PRN | | SOLE | | 13,000,000 | 0 | 0 |
Aetna Inc. | Common | 00817Y108 | 8,039 | 47,566 | SH | | SOLE | | 47,566 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 3,340 | 1,805,324 | SH | | SOLE | | 1,805,324 | 0 | 0 |
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 230 | 2,810 | SH | | SOLE | | 2,810 | 0 | 0 |
Akebia Therapeutics, Inc. | Common | 00972D105 | 1,266 | 132,849 | SH | | SOLE | | 132,849 | 0 | 0 |
Albireo Pharma, Inc. | Common | 01345P106 | 4,071 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
Alder Biopharmaceuticals, Inc. | Common | 014339105 | 3,555 | 279,950 | SH | | SOLE | | 279,950 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 55,616 | 498,975 | SH | | SOLE | | 498,975 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 12,182 | 210,182 | SH | | SOLE | | 210,182 | 0 | 0 |
Allergan plc | Shares | G0177J108 | 41,877 | 248,836 | SH | | SOLE | | 248,836 | 0 | 0 |
Alliqua BioMedical, Inc. | Common | 019621309 | 318 | 165,000 | SH | | SOLE | | 165,000 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 15,528 | 130,376 | SH | | SOLE | | 130,376 | 0 | 0 |
Amarin Corporation plc | Sponsored ADR | 023111206 | 1,439 | 478,149 | SH | | SOLE | | 478,149 | 0 | 0 |
AmerisourceBergen Corporation | Common | 03073E105 | 7,992 | 92,707 | SH | | SOLE | | 92,707 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 119,436 | 700,588 | SH | | SOLE | | 700,588 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 13,165 | 875,304 | SH | | SOLE | | 875,304 | 0 | 0 |
Anthem, Inc. | Common | 036752103 | 20,099 | 91,482 | SH | | SOLE | | 91,482 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y407 | 405 | 811,227 | SH | | SOLE | | 811,227 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 3,229 | 639,370 | SH | | SOLE | | 639,370 | 0 | 0 |
Arena Pharmaceuticals, Inc. | Common | 040047607 | 665 | 16,827 | SH | | SOLE | | 16,827 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 3,132 | 38,931 | SH | | SOLE | | 38,931 | 0 | 0 |
Array BioPharma Inc. | Common | 04269X105 | 2,547 | 156,056 | SH | | SOLE | | 156,056 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 406 | 6,214 | SH | | SOLE | | 6,214 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 15,478 | 442,600 | SH | | SOLE | | 442,600 | 0 | 0 |
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 5,938 | 814,588 | SH | | SOLE | | 814,588 | 0 | 0 |
AveXis, Inc. | Common | 05366U100 | 8,693 | 70,347 | SH | | SOLE | | 70,347 | 0 | 0 |
Baxter International Inc. | Sponsored ADR | 071813109 | 2,599 | 39,965 | SH | | SOLE | | 39,965 | 0 | 0 |
Becton, Dickinson and Company | Common | 075887109 | 3,739 | 17,254 | SH | | SOLE | | 17,254 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 8,315 | 49,496 | SH | | SOLE | | 49,496 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 394 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 103,696 | 378,703 | SH | | SOLE | | 378,703 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd. | Common | G11196105 | 4,185 | 162,477 | SH | | SOLE | | 162,477 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 22,787 | 281,076 | SH | | SOLE | | 281,076 | 0 | 0 |
bluebird Bio, Inc. | Common | 09609G100 | 11,322 | 66,308 | SH | | SOLE | | 66,308 | 0 | 0 |
Blueprint Medicines Corporation | Common | 09627Y109 | 6,806 | 74,221 | SH | | SOLE | | 74,221 | 0 | 0 |
Boston Scientific Corporation | Common | 101137107 | 12,501 | 457,585 | SH | | SOLE | | 457,585 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 33,252 | 525,722 | SH | | SOLE | | 525,722 | 0 | 0 |
Cardinal Health, Inc. | Common | 14149Y108 | 395 | 6,300 | SH | | SOLE | | 6,300 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 120,687 | 1,352,842 | SH | | SOLE | | 1,352,842 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B103 | 247 | 105,800 | SH | | SOLE | | 105,800 | 0 | 0 |
Cellectis S.A. | Sponsored ADR | 15117K103 | 8,925 | 283,250 | SH | | SOLE | | 283,250 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 24,597 | 230,158 | SH | | SOLE | | 230,158 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 2,420 | 22,670 | SH | | SOLE | | 22,670 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 635 | 158,784 | SH | | SOLE | | 158,784 | 0 | 0 |
Cigna Corporation | Common | 125509109 | 9,488 | 56,563 | SH | | SOLE | | 56,563 | 0 | 0 |
Clovis Oncology, Inc. | Common | 189464100 | 3,981 | 75,400 | SH | | SOLE | | 75,400 | 0 | 0 |
Coherus BioSciences, Inc. | Common | 19249H103 | 2,000 | 181,023 | SH | | SOLE | | 181,023 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 808 | 203,935 | SH | | SOLE | | 203,935 | 0 | 0 |
CRISPR Therapeutics AG | Common | H17182108 | 6,454 | 141,191 | SH | | SOLE | | 141,191 | 0 | 0 |
CVS Health Corporation | Common | 126650100 | 22,801 | 366,521 | SH | | SOLE | | 366,521 | 0 | 0 |
Cymabay Therapeutics, Inc. | Common | 23257D103 | 2,208 | 169,962 | SH | | SOLE | | 169,962 | 0 | 0 |
Cytokinetics, Incorporated | Common | 23282W605 | 992 | 137,797 | SH | | SOLE | | 137,797 | 0 | 0 |
CytomX Therapeutics, Inc. | Common | 23284F105 | 7,541 | 265,045 | SH | | SOLE | | 265,045 | 0 | 0 |
Danaher Corporation | Common | 235851102 | 7,328 | 74,847 | SH | | SOLE | | 74,847 | 0 | 0 |
Dermira, Inc. | Common | 24983L104 | 1,871 | 234,200 | SH | | SOLE | | 234,200 | 0 | 0 |
Diplomat Pharmacy, Inc. | Common | 25456K101 | 8,846 | 439,001 | SH | | SOLE | | 439,001 | 0 | 0 |
Editas Medicine, Inc. | Common | 28106W103 | 4,568 | 137,801 | SH | | SOLE | | 137,801 | 0 | 0 |
Edwards Lifesciences Corporation | Common | 28176E108 | 9,247 | 66,275 | SH | | SOLE | | 66,275 | 0 | 0 |
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 2,586 | 7,000,000 | PRN | | SOLE | | 7,000,000 | 0 | 0 |
Eiger BioPharmaceuticals, Inc. | Common | 28249U105 | 452 | 45,854 | SH | | SOLE | | 45,854 | 0 | 0 |
Eli Lilly and Company | Common | 532457108 | 37,669 | 486,865 | SH | | SOLE | | 486,865 | 0 | 0 |
Endo International plc | Shares | G30401106 | 5,432 | 914,548 | SH | | SOLE | | 914,548 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 8,615 | 485,325 | SH | | SOLE | | 485,325 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 13,691 | 189,287 | SH | | SOLE | | 189,287 | 0 | 0 |
Evolent Health, Inc. | Class A | 30050B101 | 1,746 | 122,500 | SH | | SOLE | | 122,500 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 8,612 | 388,822 | SH | | SOLE | | 388,822 | 0 | 0 |
Express Scripts Holding Company | Common | 30219G108 | 7,357 | 106,500 | SH | | SOLE | | 106,500 | 0 | 0 |
FibroGen, Inc. | Common | 31572Q808 | 4,819 | 104,307 | SH | | SOLE | | 104,307 | 0 | 0 |
Foamix Pharmaceuticals Ltd | Shares | M46135105 | 4,773 | 930,398 | SH | | SOLE | | 930,398 | 0 | 0 |
Foundation Medicine, Inc. | Common | 350465100 | 500 | 6,353 | SH | | SOLE | | 6,353 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 9,541 | 95,635 | SH | | SOLE | | 95,635 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 155,582 | 2,063,699 | SH | | SOLE | | 2,063,699 | 0 | 0 |
Glaukos Corporation | Common | 377322102 | 1,698 | 55,079 | SH | | SOLE | | 55,079 | 0 | 0 |
GlaxoSmithKline plc | Shares | 37733W105 | 15,423 | 394,749 | SH | | SOLE | | 394,749 | 0 | 0 |
Global Blood Therapeutics, Inc. | Common | 37890U108 | 6,276 | 129,948 | SH | | SOLE | | 129,948 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 510 | 73,400 | SH | | SOLE | | 73,400 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 12,482 | 110,784 | SH | | SOLE | | 110,784 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 8,912 | 91,881 | SH | | SOLE | | 91,881 | 0 | 0 |
HCP, Inc. | Common | 40414L109 | 1,057 | 45,500 | SH | | SOLE | | 45,500 | 0 | 0 |
Healthcare Realty Trust Incorporated | Common | 421946104 | 1,884 | 68,000 | SH | | SOLE | | 68,000 | 0 | 0 |
Healthcare Trust of America, Inc. | Class A | 42225P501 | 1,217 | 46,000 | SH | | SOLE | | 46,000 | 0 | 0 |
Henry Schein, Inc. | Common | 806407102 | 2,110 | 31,400 | SH | | SOLE | | 31,400 | 0 | 0 |
Hologic, Inc. | Common | 436440101 | 730 | 19,546 | SH | | SOLE | | 19,546 | 0 | 0 |
Horizon Pharma plc | Shares | G4617B105 | 2,313 | 162,900 | SH | | SOLE | | 162,900 | 0 | 0 |
Humana Inc. | Common | 444859102 | 31,919 | 118,733 | SH | | SOLE | | 118,733 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 29,297 | 153,076 | SH | | SOLE | | 153,076 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 69,718 | 294,892 | SH | | SOLE | | 294,892 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 53,785 | 645,442 | SH | | SOLE | | 645,442 | 0 | 0 |
Innoviva, Inc. | Common | 45781M101 | 2,694 | 161,603 | SH | | SOLE | | 161,603 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 3,530 | 167,381 | SH | | SOLE | | 167,381 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 5,870 | 14,218 | SH | | SOLE | | 14,218 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 7,303 | 165,677 | SH | | SOLE | | 165,677 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 18,494 | 122,482 | SH | | SOLE | | 122,482 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 114,448 | 893,082 | SH | | SOLE | | 893,082 | 0 | 0 |
Jounce Therapeutics, Inc. | Common | 481116101 | 226 | 10,127 | SH | | SOLE | | 10,127 | 0 | 0 |
Koninklijke Philips N.V. | NY Registry Shares | 500472303 | 2,886 | 75,335 | SH | | SOLE | | 75,335 | 0 | 0 |
Lexicon Pharmaceuticals, Inc. | Common | 528872302 | 1,980 | 231,054 | SH | | SOLE | | 231,054 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 7,968 | 209,673 | SH | | SOLE | | 209,673 | 0 | 0 |
Mallinckrodt plc | Shares | G5785G107 | 896 | 61,900 | SH | | SOLE | | 61,900 | 0 | 0 |
Masimo Corporation | Common | 574795100 | 3,665 | 41,666 | SH | | SOLE | | 41,666 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 13,918 | 98,797 | SH | | SOLE | | 98,797 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 11,162 | 858,586 | SH | | SOLE | | 858,586 | 0 | 0 |
The Medicines Company | Common | 584688105 | 9,170 | 278,391 | SH | | SOLE | | 278,391 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 41,892 | 522,211 | SH | | SOLE | | 522,211 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 69,941 | 1,284,022 | SH | | SOLE | | 1,284,022 | 0 | 0 |
Merus B.V. | Common | N5749R100 | 8,879 | 479,150 | SH | | SOLE | | 479,150 | 0 | 0 |
Molecular Templates, Inc. | Common | 608550109 | 423 | 52,891 | SH | | SOLE | | 52,891 | 0 | 0 |
Mylan N.V. | Shares | N59465109 | 71,099 | 1,726,967 | SH | | SOLE | | 1,726,967 | 0 | 0 |
Myovant Sciences Ltd. | Common | G637AM102 | 3,201 | 150,471 | SH | | SOLE | | 150,471 | 0 | 0 |
NanoString Technologies, Inc. | Common | 63009R109 | 558 | 74,250 | SH | | SOLE | | 74,250 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 962 | 103,731 | SH | | SOLE | | 103,731 | 0 | 0 |
Natus Medical Incorporated | Common | 639050103 | 381 | 11,335 | SH | | SOLE | | 11,335 | 0 | 0 |
Nektar Therapeutics | Common | 640268108 | 13,231 | 124,517 | SH | | SOLE | | 124,517 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 23,172 | 279,419 | SH | | SOLE | | 279,419 | 0 | 0 |
Nevro Corp. | Common | 64157F103 | 4,593 | 52,990 | SH | | SOLE | | 52,990 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 7,230 | 883,919 | SH | | SOLE | | 883,919 | 0 | 0 |
NewLink Genetics Corporation | Common | 651511107 | 1,486 | 205,026 | SH | | SOLE | | 205,026 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 28,380 | 351,020 | SH | | SOLE | | 351,020 | 0 | 0 |
Novavax, Inc. | Common | 670002104 | 1,199 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 6,693 | 135,900 | SH | | SOLE | | 135,900 | 0 | 0 |
NuCana plc | Sponsored ADR | 67022C106 | 464 | 24,536 | SH | | SOLE | | 24,536 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 15,677 | 579,785 | SH | | SOLE | | 579,785 | 0 | 0 |
Ovid Therapeutics Inc. | Common | 690469101 | 3,788 | 535,824 | SH | | SOLE | | 535,824 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 3,109 | 37,300 | SH | | SOLE | | 37,300 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 72,823 | 2,051,943 | SH | | SOLE | | 2,051,943 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 4,131 | 265,336 | SH | | SOLE | | 265,336 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 14,236 | 2,087,380 | SH | | SOLE | | 2,087,380 | 0 | 0 |
Portola Pharmaceuticals, Inc. | Common | 737010108 | 2,939 | 89,978 | SH | | SOLE | | 89,978 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 2,693 | 32,460 | SH | | SOLE | | 32,460 | 0 | 0 |
Protagonist Therapeutics, Inc. | Common | 74366E102 | 1,882 | 219,042 | SH | | SOLE | | 219,042 | 0 | 0 |
PTC Therapeutics, Inc. | Common | 69366J200 | 658 | 24,299 | SH | | SOLE | | 24,299 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 3,810 | 55,985 | SH | | SOLE | | 55,985 | 0 | 0 |
Quorum Health Corporation | Common | 74909E106 | 194 | 23,725 | SH | | SOLE | | 23,725 | 0 | 0 |
Quotient Limited | Shares | G73268107 | 2,084 | 442,461 | SH | | SOLE | | 442,461 | 0 | 0 |
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 1,798 | 338,565 | SH | | SOLE | | 338,565 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 48,059 | 139,560 | SH | | SOLE | | 139,560 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 3,330 | 33,819 | SH | | SOLE | | 33,819 | 0 | 0 |
Revance Therapeutics, Inc. | Common | 761330109 | 1,335 | 43,329 | SH | | SOLE | | 43,329 | 0 | 0 |
The RMR Group Inc. | Class A | 74967R106 | 520 | 7,441 | SH | | SOLE | | 7,441 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 12,789 | 724,606 | SH | | SOLE | | 724,606 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 20,077 | 124,650 | SH | | SOLE | | 124,650 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 7,210 | 179,900 | SH | | SOLE | | 179,900 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 28,044 | 378,516 | SH | | SOLE | | 378,516 | 0 | 0 |
Seattle Genetics, Inc. | Common | 812578102 | 18,136 | 346,499 | SH | | SOLE | | 346,499 | 0 | 0 |
Senior Housing Properties Trust | Shares | 81721M109 | 10,125 | 646,554 | SH | | SOLE | | 646,554 | 0 | 0 |
Shire plc | Sponsored ADR | 82481R106 | 17,274 | 115,629 | SH | | SOLE | | 115,629 | 0 | 0 |
Smith & Nephew plc | Sponsored ADR | 83175M205 | 1,684 | 44,148 | SH | | SOLE | | 44,148 | 0 | 0 |
Spark Therapeutics, Inc. | Common | 84652J103 | 1,468 | 22,046 | SH | | SOLE | | 22,046 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 21,973 | 250,460 | SH | | SOLE | | 250,460 | 0 | 0 |
STERIS plc | Shares | G84720104 | 1,551 | 16,612 | SH | | SOLE | | 16,612 | 0 | 0 |
Stryker Corporation | Common | 863667101 | 10,340 | 64,258 | SH | | SOLE | | 64,258 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 2,846 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Teleflex Incorporated | Common | 879369106 | 633 | 2,482 | SH | | SOLE | | 2,482 | 0 | 0 |
Teligent, Inc. | Common | 87960W104 | 1,853 | 551,429 | SH | | SOLE | | 551,429 | 0 | 0 |
Tenet Healthcare Corporation | Common | 88033G407 | 3,989 | 164,500 | SH | | SOLE | | 164,500 | 0 | 0 |
TESARO, Inc. | Common | 881569107 | 3,291 | 57,595 | SH | | SOLE | | 57,595 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 2,638 | 859,322 | SH | | SOLE | | 859,322 | 0 | 0 |
Teva Pharmaceutical Industries Limited | Sponsored ADR | 881624209 | 18,512 | 1,083,223 | SH | | SOLE | | 1,083,223 | 0 | 0 |
TherapeuticsMD, Inc. | Common | 88338N107 | 2,283 | 468,769 | SH | | SOLE | | 468,769 | 0 | 0 |
Theravance Biopharma, Inc. | Common | G8807B106 | 196 | 8,083 | SH | | SOLE | | 8,083 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 30,526 | 147,855 | SH | | SOLE | | 147,855 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 3,372 | 468,399 | SH | | SOLE | | 468,399 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 7,575 | 148,558 | SH | | SOLE | | 148,558 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 4,694 | 199,750 | SH | | SOLE | | 199,750 | 0 | 0 |
United Therapeutics Corporation | Common | 91307C102 | 4,636 | 41,261 | SH | | SOLE | | 41,261 | 0 | 0 |
Unitedhealth Group Incorporated | Common | 91324P102 | 75,396 | 352,317 | SH | | SOLE | | 352,317 | 0 | 0 |
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 3,057 | 192,000 | SH | | SOLE | | 192,000 | 0 | 0 |
Varian Medical Systems, Inc. | Common | 92220P105 | 621 | 5,065 | SH | | SOLE | | 5,065 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 4,358 | 87,996 | SH | | SOLE | | 87,996 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 5,500 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 100,083 | 614,084 | SH | | SOLE | | 614,084 | 0 | 0 |
Welltower Inc. | 6.50% Preferred Perpetual | 95040Q203 | 11,128 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 1,165 | 21,400 | SH | | SOLE | | 21,400 | 0 | 0 |
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 5,293 | 266,781 | SH | | SOLE | | 266,781 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 600 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 1,372 | 280,000 | SH | | SOLE | | 280,000 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 8,950 | 82,080 | SH | | SOLE | | 82,080 | 0 | 0 |